A股異動 | 聯特科技5日飆升逾80% 目前正在積極建設CPO核心技術和工藝平台
格隆匯2月10日丨聯特科技漲4.48%,報76.05元,近五個交易日累計漲幅超80%,最新總市值55億元。聯特科技昨日盤後發佈股票交易異常波動公吿,近日公司注意到CPO等話題在行業內引起廣泛的討論和關注。經核查,CPO是在AI應用等大算力應用場景下光模塊的技術和產品演進的方向之一,但目前CPO相關產品開發還處於初期階段,技術的成熟及市場的規模化應用還有待時日,也存在諸多不確定性。公司目前正在積極建設CPO核心技術和工藝平台,包括各類光學元件與電芯片的共封裝工藝的設計和開發平台,能否實現技術突破和完成技術成果的產業化及商業化存在不確定性。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.